Cargando…
MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452036/ http://dx.doi.org/10.1016/j.jtho.2022.07.122 |
| _version_ | 1784784855978999808 |
|---|---|
| author | Fenemore, J. Boerckel, W. Rigney, M. McNamara, A. Gaspar, B. Mayans, J. Hennink, M. Fox, J. Pretorius, L. Daniels, M. Winstone, S. Thakrar, R. |
| author_facet | Fenemore, J. Boerckel, W. Rigney, M. McNamara, A. Gaspar, B. Mayans, J. Hennink, M. Fox, J. Pretorius, L. Daniels, M. Winstone, S. Thakrar, R. |
| author_sort | Fenemore, J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9452036 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94520362022-09-08 MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey Fenemore, J. Boerckel, W. Rigney, M. McNamara, A. Gaspar, B. Mayans, J. Hennink, M. Fox, J. Pretorius, L. Daniels, M. Winstone, S. Thakrar, R. J Thorac Oncol Ma08 Patient Advocacy and Patient Preferences, Monday, August 8, 2022 - 12:15 - 13:15 Published by Elsevier Inc. 2022-09 2022-09-08 /pmc/articles/PMC9452036/ http://dx.doi.org/10.1016/j.jtho.2022.07.122 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Ma08 Patient Advocacy and Patient Preferences, Monday, August 8, 2022 - 12:15 - 13:15 Fenemore, J. Boerckel, W. Rigney, M. McNamara, A. Gaspar, B. Mayans, J. Hennink, M. Fox, J. Pretorius, L. Daniels, M. Winstone, S. Thakrar, R. MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey |
| title | MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey |
| title_full | MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey |
| title_fullStr | MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey |
| title_full_unstemmed | MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey |
| title_short | MA08.07 Understanding Lung Cancer Patients’ Preferences in Speaking to Their Treatment Team: Insights from a Global Patient Experience Survey |
| title_sort | ma08.07 understanding lung cancer patients’ preferences in speaking to their treatment team: insights from a global patient experience survey |
| topic | Ma08 Patient Advocacy and Patient Preferences, Monday, August 8, 2022 - 12:15 - 13:15 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452036/ http://dx.doi.org/10.1016/j.jtho.2022.07.122 |
| work_keys_str_mv | AT fenemorej ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT boerckelw ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT rigneym ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT mcnamaraa ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT gasparb ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT mayansj ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT henninkm ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT foxj ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT pretoriusl ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT danielsm ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT winstones ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey AT thakrarr ma0807understandinglungcancerpatientspreferencesinspeakingtotheirtreatmentteaminsightsfromaglobalpatientexperiencesurvey |